Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Virtual Advocacy Saves Time, Extends Reach

Kimberly Retzlaff  |  April 15, 2021

A few years ago, Mohammad Kamran, MD, a rheumatologist at Wellstar Health System in Marietta, Ga., got involved in advocacy as a way to help protect patients with rheumatic disease. The catalyst for his action was the tragic death of a patient, a 22-year-old Black woman with lupus. The young woman had been diagnosed years before, but because she was uninsured, she couldn’t afford medication or regular visits to her doctor. She was admitted to the hospital suffering from severe heart failure and kidney failure. Despite the healthcare team’s best efforts, she didn’t survive.

Dr. Kamran decided he wasn’t going to complain—he was going to take action. Shortly after, he met with some of his state legislators to tell them about his patient and to talk about the challenges facing patients with rheumatic disease.

headshot of Mohammad Kamran

Dr. Kamran

Advocacy continues to be an important part of Dr. Kamran’s professional mission, and he recently joined the ACR Government Affairs Committee (GAC) to get involved at a higher level. He spoke with The Rheumatologist about his experience and why advocacy is critical during the COVID-19 pandemic and beyond.

The Rheumatologist (TR): Why is advocacy still important in the midst of a public health emergency?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Kamran: This pandemic is different than any other public health emergency would be. I mean, it’s kept everybody at home. Everything changed, so advocacy even became more important to educate our legislators, bring forth the problems that we will be facing or that we are facing and talk to them about how they can help us navigate those problems.

TR: How has the COVID-19 pandemic changed how you approach rheumatology advocacy?

Dr. Kamran: The pandemic may have made it a little easier, ironically. Previously, if I was going to go to the Hill, I had to close my office and take time off for in-person meetings. In-person meetings are very productive, and I would love to go back to that as well, but what is different is now it is easier to get involved because we can advocate virtually without leaving our offices or hometowns. This way one can be more involved and reach out to more legislators.

TR: Does your position in a large, multi-specialty group in Georgia affect how you approach advocacy?

Dr. Kamran: No. I always keep the patients in the forefront. They are the center, and they should be the center of everything we do and advocate for.

Page: 1 2 | Single Page
Share: 

Filed under:Legislation & AdvocacyProfiles Tagged with:AdvocacyGovernment Affairs Committee (GAC)Mohammad Kamran

Related Articles

    4 ARP Members Talk About Their Roads to Advocacy & Why It Matters

    May 13, 2021

    The Budget Control Act of 2011 cut Medicare physician payments by 2% across the board. The Coronavirus Aid, Relief, and Economic Security (CARES) Act, signed into law in 2020, suspended this sequester (i.e., a cut in government spending) between May 1 and Dec. 31, 2020. In the Consolidated Appropriations Act, signed into law in December…

    Providers & Patients Talk to Legislators about Telehealth, Workforce Shortage

    September 18, 2020

    On Sept. 15, rheumatology advocates met virtually with members of Congress to share personal accounts of how telehealth is making a difference during the COVID-19 pandemic and what will help stem a workforce shortage.

    Capitol Hill Rheumatology Advocacy Goes Virtual

    May 11, 2020

    ACR volunteer leaders and staff will convene more than 100 meetings via teleconference with Congressional leaders on May 22, addressing rheumatology provider solvency and patient access to care amidst the COVID-19 pandemic.

    Advocacy in a COVID-19 America

    June 15, 2020

    These are truly extraordinary times. The COVID-19 pandemic has affected the rheumatology community, both providers and patients, in many ways, and our advocacy efforts are now more important than ever to ensure policymakers hear us and help address the issues facing our community. As with so many things during this pandemic, we are reimagining advocacy…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences